Many patients with diabetes do not receive recommended standards of care. Diabetes patients were seen by a pharmacist in a diabetes assessment service (DAS) 1 week prior to a physician appointment to complete diabetes standards. Completion rates of American Diabetes Association (ADA) standards were compared between patients of 5 physicians offered the DAS intervention and a concurrent cohort of randomly selected patients of nonparticipating physicians. A total of 94 patients were seen by DAS; 210 patients comprised the controls. DAS patients had a significantly higher proportion of each standard completed (glycosylated hemoglobin, lipids, foot exam, eye referral, pneumococcal and influenza vaccination, and urine microalbumin) compared with the control group (P < .001). An average of 3.3 ± 1.8 diabetes standards per patient were completed. A planned visit with a pharmacist prior to a physician appointment, with the goal of completing ADA standards of care, was feasible and effective in this university-based family medicine center.
American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
2.
OstbyeTYarnallKSKrauseKMPollakKIGradisonMMichenerJL.Is there time for management of patients with chronic diseases in primary care?Ann Fam Med. 2005;3:209-214.
3.
KernDHMainousAGIII. Disease management for diabetes among family physicians and general internists: opportunism or planned care?Fam Med. 2001;33:621-625.
4.
CheungBMOngKLChernySSShamPCTsoAWLamKS.Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122:443-453.
5.
VouriSMShawRFWaterburyNVEggeJAAlexanderB.Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes. J Manag Care Pharm. 2011;17:304-312.
6.
YarnallKSPollakKIOstbyeTKrauseKMMichenerJL.Primary care: is there enough time for prevention?Am J Public Health. 2003;93:635-641.
7.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA: US Departent of Health and Human Services, Centers for Disease Control and Prevention; 2008.
8.
CarsonJJ.Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults. Am J Health Syst Pharm. 1999;56:2319-2324.
9.
WhitleyHPFermoJDChumneyEC.5-Year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease. Pharmacotherapy. 2006;26:682-688.
10.
LeeSSCheungPYChowMS.Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol. 2004;44:632-639.
11.
YuGCBeresfordR.Implementation of a chronic illness model for diabetes care in a family medicine residency program. J Gen Intern Med. 2010;25(suppl 4):S615-S619.
12.
MooreLG.Escaping the tyranny of the urgent by delivering planned care. Fam Pract Manag. 2006;13:37-40.
13.
NuttingPADickinsonWPDickinsonLM. Use of chronic care model elements is associated with higher-quality care for diabetes. Ann Fam Med. 2007;5:14-20.
14.
WagnerEHAustinBTVon KorffM.Organizing care for patients with chronic illness. Milbank Q. 1996;74:511-544.
15.
WagnerEHGrothausLCSandhuN. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care. 2001;24:695-700.
16.
BarudSMarcyTArmorBChonlahanJBeachP.Development and implementation of group medical visits at a family medicine center. Am J Health Syst Pharm. 2006;63: 1448-1452.
17.
KimuraJDaSilvaKMarshallR.Population management, systems-based practice, and planned chronic illness care: integrating disease management competencies into primary care to improve composite diabetes quality measures. Dis Manag. 2008;11:13-22.
18.
JohnsonKAChenSChengIN. The impact of clinical pharmacy services integrated into medical homes on diabetes-related clinical outcomes. Ann Pharmacother. 2010;44:1877-1886.
19.
Chisholm-BurnsMAKim LeeJSpiveyCA. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48: 923-933.
SmithMBatesDWBodenheimerTClearyPD.Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29:906-913.
22.
McCordAD.Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248-253.
23.
OdegardPSGooAHummelJWilliamsKLGraySL.Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433-440.
24.
ScottDMBoydSTStephanMAugustineSCReardonTP.Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm. 2006;63:2116-2122.
25.
IronsBKSeifertCFHortonNA.Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic. Diabetes Technol Ther. 2008;10: 220-226.
26.
CranorCWBuntingBAChristensenDB.The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43:173-184.
27.
LetassyNAArmorBLBrittonMFarmerK.Pharmacist- managed diabetes service in a family medicine practice improves patient outcomes. Drug Benefit Trends. 2003; 15(suppl):21-32.
28.
ArmorBLBrittonMLDennisVCLetassyNA.A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23:250-264.
